1 – 10 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Sputum from Individuals with Primary Ciliary Dyskinesia Drives M2-like Macrophage Polarization
- Contribution to journal › Article
-
Mark
Elexacaftor–tezacaftor–ivacaftor enhances first-phase insulin secretion and improves glucose control in cystic fibrosis
- Contribution to journal › Article
- 2025
-
Mark
Performance of quantitative PCR to distinguish Pneumocystis jirovecii pneumonia from colonisation in mmunocompromised patients
- Contribution to journal › Article
-
Mark
Characterisation of airway inflammation and proteomes associated with cystic fibrosis-related diabetes
- Contribution to journal › Article
-
Mark
Antibody-guided identification of Achromobacter xylosoxidans protein antigens in cystic fibrosis.
- Contribution to journal › Article
-
Mark
Frequency of haematogenous periprosthetic joint infection due to bacteraemia caused by gram-positive cocci
- Contribution to journal › Article
-
Mark
The effect of elexacaftor-tezacaftor-ivacaftor on liver stiffness in children with cystic fibrosis
- Contribution to journal › Article
-
Mark
The cystic fibrosis pathogen Achromobacter xylosoxidans inhibits biofilm formation of Pseudomonas aeruginosa
- Contribution to journal › Article
-
Mark
Prevalence and risk factors for haematogenous periprosthetic joint infection during Staphylococcus aureus bacteraemia
- Contribution to journal › Article
- 2024
-
Mark
Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden : a prospective multicentre cohort study
- Contribution to journal › Article
